Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-048262
Filing Date
2013-09-09
Accepted
2013-09-09 16:48:58
Documents
2
Period of Report
2013-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 - CHRISTOPHER ALAFI, PH.D. rrd389849.html 3  
1 FORM 3 - CHRISTOPHER ALAFI, PH.D. rrd389849.xml 3 6046
2 POWER OF ATTORNEY - CHRISTOPHER ALAFI, PH.D. rrd350737_397141.htm EX-24.1 4001
  Complete submission text file 0001181431-13-048262.txt   11461
Mailing Address P.O. BOX 7338 BERKELEY CA 94707
Business Address
Alafi Christopher D (Reporting) CIK: 0001299430 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54896 | Film No.: 131086117

Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations